title: Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero.
authors.forename: P
authors.initials: P
authors.lastname: Gazzaniga
authors.forename: C
authors.initials: C
authors.lastname: Raimondi
authors.forename: A
authors.initials: A
authors.lastname: Gradilone
authors.forename: M
authors.initials: M
authors.lastname: Di Seri
authors.forename: F
authors.initials: F
authors.lastname: Longo
authors.forename: E
authors.initials: E
authors.lastname: Cortesi
authors.forename: L
authors.initials: L
authors.lastname: Frati
mesh_terms: D000230:Adenocarcinoma / Q000097:blood* / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000097:blood* / Q000188:drug therapy*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000401:mortality*; D004730:Endothelium, Vascular / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D009360:Neoplastic Cells, Circulating / Q000473:pathology*